Sickle Cell Disease News

First SCD patient enrolled in Phase 1b trial of oral therapy iadademstat

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...

Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...

Beam Therapeutics: SCD Catalysts Have Untapped Upside Potential

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...
Medscape

Sickle Cell: New Hope for Preeclampsia Detection?

Placental growth factor shows 100% accuracy for early preeclampsia detection in sickle cell disease, new research indicates.
Washington Square News

Musicians destigmatize sickle cell disease with NYU researchers

NYU researchers partnered with Nigerian singer Adekunle Gold to launch an organization that uses music to reduce stigma and ...